Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1Beatriz Mothe, Constanza Lucero, Montserrat Plana et al.|Journal of Antimicrobial Chemotherapy|2015Cited by 65
Removal of the C6 vaccinia virus interferon-β inhibitor in the hepatitis C vaccine candidate MVA-HCV elicited in mice high immunogenicity in spite of reduced host gene expressionMaría Q. Marín, Juan García‐Arriaza|bioRxiv (Cold Spring Harbor Laboratory)|2018Cited by 8